GSK-239512 structure
|
Common Name | GSK-239512 | ||
---|---|---|---|---|
CAS Number | 720691-69-0 | Molecular Weight | 377.479 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 607.6±55.0 °C at 760 mmHg | |
Molecular Formula | C23H27N3O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 321.3±31.5 °C |
Use of GSK-239512GSK239512 is a potent and brain penetrated H3 receptor antagonist. GSK239512 can be used for the research of mild-to-moderate Alzheimer's disease (AD)[1]. |
Name | GSK-239512 |
---|---|
Synonym | More Synonyms |
Description | GSK239512 is a potent and brain penetrated H3 receptor antagonist. GSK239512 can be used for the research of mild-to-moderate Alzheimer's disease (AD)[1]. |
---|---|
Related Catalog | |
Target |
H3 receptor |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 607.6±55.0 °C at 760 mmHg |
Molecular Formula | C23H27N3O2 |
Molecular Weight | 377.479 |
Flash Point | 321.3±31.5 °C |
Exact Mass | 377.210327 |
LogP | 2.94 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.627 |
Storage condition | 2-8°C |
2-Pyrrolidinone, 1-[6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl]- |
MFCD27922168 |
GSK-239512 |
1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone |